Search

Pradeep G Bhide

from Tallahassee, FL
Age ~66

Pradeep Bhide Phones & Addresses

  • 3550 Esplanade Way APT 3201, Tallahassee, FL 32311 (850) 597-9961
  • Peabody, MA
  • 11 Pye Brook Ln, Boxford, MA 01921 (978) 887-0921
  • 1 Crescent St, Wakefield, MA 01880 (781) 245-4610
  • Allston, MA
  • New Haven, CT
  • 1 Crescent St APT 3, Wakefield, MA 01880

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

Degree: Bachelor's degree or higher

Resumes

Resumes

Pradeep Bhide Photo 1

Co-Founder

View page
Location:
Tallahassee, FL
Industry:
Higher Education
Work:
Anxiolytech
Co-Founder

Thrivant
Co-Founder

Sunshinenano
Co-Founder

Avekshan
Co Founder

Massachusetts General Hospital Oct 1988 - Oct 2011
Vice Chair For Neurology Research
Education:
Harvard Medical School 1990
Yale University School of Medicine
Ucl
University of Aberdeen
Doctorates, Doctor of Philosophy, Philosophy, Neuroscience
Veterinary College, Bangalore, India
Bachelors, Bachelor of Veterinary Science, Medicine
Skills:
Neuroscience
Neurology
Molecular Biology
Biochemistry
Cell Biology
Genetics
Research
Animal Models
Fluorescence Microscopy
Pharmacology
Immunohistochemistry
Cell Culture
Science
Developmental Biology
Molecular Genetics
Western Blotting
Microscopy
Life Sciences
Developmental Disabilities
Developmental Psychopathology
Adhd
Movement Disorders
Dystonia
Addiction Medicine
Developmental Psychology
Alzheimer's Care
Alzheimer's Disease
Genomics
Pradeep Bhide Photo 2

Pradeep Bhide

View page
Pradeep Bhide Photo 3

Pradeep Bhide

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Pradeep G. Bhide
Manager
Avexan LLC
3550 Esplanade Way, Tallahassee, FL 32311
Pradeep G Bhide
Manager
KAMALA BIOPHARMA LLC
3550 Esplanade Way #3201, Tallahassee, FL 32311

Publications

Us Patents

Methods And Compositions To Prevent Addiction

View page
US Patent:
20120302590, Nov 29, 2012
Filed:
Aug 13, 2010
Appl. No.:
13/389959
Inventors:
Pradeep G. Bhide - Peabody MA, US
Jinmin Zhu - Allston MA, US
Thomas J. Spencer - Carlisle MA, US
Joseph Biederman - Brookline MA, US
Assignee:
THE GENERAL HOSPITAL CORPORATION - Boston MA
International Classification:
A61K 31/485
A61P 25/04
US Classification:
514282
Abstract:
Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject comprising, administering a therapeutic amount of the neurological stimulant and administering an antagonist of the kappa opioid receptor, to thereby reduce or prevent the development of aversion to the CNS stimulant in the subject. Also disclosed is a method of reducing or preventing the development of addiction to a CNS stimulant in a subject, comprising, administering the CNS stimulant and administering a mu opioid receptor antagonist to thereby reduce or prevent the development of addiction to the CNS stimulant in the subject. Also disclosed are pharmaceutical compositions comprising a central nervous system stimulant and an opioid receptor antagonist. Examples of central nervous system stimulants (such as methylphenidate) and opioid receptor antagonists (such as naltrexone) are provided.
Pradeep G Bhide from Tallahassee, FL, age ~66 Get Report